Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia 16Breast Neoplasms 6Lymphoma 5Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Follicular 3Congenital Abnormalities 3Wilms Tumor 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Precancerous Conditions 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 41Radiotherapy 32Fluorouracil 14Paclitaxel 13Docetaxel 12Cetuximab 12Radiotherapy, Intensity-Modulated 9Carboplatin 8Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 4Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Chemotherapy, Adjuvant 3vandetanib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiosurgery 2Pilocarpine 2Panitumumab 2Neoadjuvant Therapy 2Lapatinib 2Isotretinoin 2In Situ Hybridization 2Fluorodeoxyglucose F18 2Filgrastim 2Epoetin Alfa 2Drug Therapy 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Head and Neck Neoplasms × Microarray Analysis × Clear all
NCT01466244 2017-05-17

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Eastern Cooperative Oncology Group

Completed
42 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡